Experimental cell therapy tested for aggressive brain cancers
NCT ID NCT07496073
Summary
This early-stage study is testing the safety of an experimental cell therapy called CHT101 for adults with recurrent or worsening malignant brain tumors. The trial will enroll 30 participants to monitor side effects and see if the treatment shows any signs of slowing tumor growth. This is a first-in-human study, so the main goal is to determine if the treatment is safe enough for further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN (NERVOUS SYSTEM) CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.